Low apolipoprotein A1 was associated with increased risk of cancer mortality in patients following percutaneous coronary intervention: A 10‐year follow‐up study

Previous studies showed that elevated apolipoprotein A1 (ApoA1) and high‐density lipoprotein cholesterol (HDL‐C) predicted reduced risk of cardiovascular‐related (CV) mortality in patients following percutaneous coronary intervention (PCI). Nevertheless, as the association between ApoA1 and cancer m...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishiyama, Hiroki, Funamizu, Takehiro, Iwata, Hiroshi, Endo, Hirohisa, Chikata, Yuichi, Doi, Shinichiro, Wada, Hideki, Naito, Ryo, Ogita, Manabu, Kato, Yoshiteru, Okai, Iwao, Dohi, Tomotaka, Kasai, Takatoshi, Isoda, Kikuo, Okazaki, Shinya, Miyauchi, Katsumi, Minamino, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Cancer Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540779/
https://www.ncbi.nlm.nih.gov/pubmed/35796324
http://dx.doi.org/10.1002/ijc.34164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540779/
https://www.ncbi.nlm.nih.gov/pubmed/35796324
http://dx.doi.org/10.1002/ijc.34164

Ejemplares similares